Abstract
About 1% of the general population suffers from epilepsy, which may leave them severely handicapped. Antiepileptic medications have a major role in the treatment of seizures in people with epilepsy (AEDs). Some of the most common drugs used to treat epilepsy have included phenobarbital, carbamazepine, valproic acid, and phenytoin. There are many AEDs licensed by the FDA since 1993 for use in the treatment of epilepsy. The kind of seizure, clinical activity range, side effect profile, and patient variables such as age, comorbidities, and concomitant medical therapies all factor into the decision to use an AED. It is common for AEDs with broad-spectrum efficacy to have many molecular targets. This chapter will examine the potential mechanisms of action of commercialized AEDs in the United States and evaluate the future of AEDs under development.
Original language | English |
---|---|
Title of host publication | How Synthetic Drugs Work |
Subtitle of host publication | Insights into Molecular Pharmacology of Classic and New Pharmaceuticals |
Publisher | Elsevier |
Pages | 177-193 |
Number of pages | 17 |
ISBN (Electronic) | 9780323998550 |
ISBN (Print) | 9780323913683 |
DOIs | |
Publication status | Published - 1 Jan 2023 |
Keywords
- anticonvulsant drugs
- epilepsy
- mechanism of action
- seizures